Evidence map›Paper›PMID 41169554›Full record

ArticleJACS Au2025

Xiao-Peng Dai, Xiang-Chun Meng, Ying-Jun Zhou, Zhi-Min Li, Yu Ji, Ulrich Schwaneberg, Zong-Lin Li

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiao-Peng DaiState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 200237 Shanghai, China.
Xiang-Chun MengState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 200237 Shanghai, China.
Ying-Jun ZhouState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 200237 Shanghai, China.ORCID https://orcid.org/0000-0003-3631-4004
Zhi-Min LiState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 200237 Shanghai, China.
Yu JiCollege of Life Science and Technology, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, 100029 Beijing, China.
Ulrich SchwanebergInstitute of Biotechnology, RWTH Aachen University, Worringerweg 3, 52074 Aachen, Germany.ORCID https://orcid.org/0000-0003-4026-701X
Zong-Lin LiState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 200237 Shanghai, China.ORCID https://orcid.org/0000-0002-1729-9593

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rational design of signal peptides represents a fundamental bottleneck in biotechnology, where sequence optimization directly governs protein secretion efficiency and industrial scalability. Current approaches rely predominantly on natural variants or empirical mutations, constraining the accessible sequence space and limiting performance gains. Here, we develop the SPgo computational framework, which overcomes these limitations by combining rule-based domain assembly with a Transformer-enabled deep generative model to support the design of Sec-type signal peptides. Our hybrid architecture constructs optimal N- and C-terminal regions through biophysical constraints while deploying a BERT-LSTM pipeline to explore vast sequence landscapes within the critical hydrophobic core. Rigorous validation of a variety of protein targets, from fluorescent proteins to industrial enzymes and bioactive peptides, showed that SPgo-designed sequences consistently outperformed natural sequences. Most notably, SPgo was able to achieve secretory production of snake venom peptides at an unprecedented yield of 154 mg/L, a 150-fold increase in target protein yield per unit culture volume compared to traditional intracellular expression, transforming previously intractable targets into viable biotechnology platforms. This work establishes a new paradigm for computational protein design, offering immediate applications in biomanufacturing while revealing the untapped potential of artificial sequence space to surpass natural evolutionary solutions. The SPgo framework data can be found on github (https://github.com/lzlinn801/SPgo).

Indexed as

BERT-LSTMcomputational designhybrid architectureprotein secretionsignal peptide

Identifiers

PMID41169554
PMCPMC12569692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.